Proceeds Purposes We plan to invest the funds raised from this financing in advancing the growing body of clinical validation for our revolutionary FluidVision intraocular lens, including completing the study that should enable us to obtain the CE Mark in Europe next year.
M&A Terms
Venture Investor Venrock
Venture Investor Johnson & Johnson Development Corporation